Oncological diseases. A. Basic scheme

Course description
The course of application along with the main treatment regimen
The isolated peptides have a powerful antitumor effect, antitoxic and immunomodulatory effects.
First month
for use in conjunction with the main treatment regimen
for use in conjunction with the main treatment regimen
672.00 €
| Indosine | Oncoprotector based on indole-3-carbinol, catalase and SOD |
| Ardiliv | Hepato- and angioprotector, source of DHQ and resveratrol |
| Mesotel Neo | Antioxidant, neuro- and hepatoprotector |
| Reviplant | Reduces intoxication, supports the liver, heart, brain, muscles and immune system |
| Vladonix №60 | Regulates the immune status |
| Panaxod | SOD source, oncoprotector and antioxidant |
| Bonomarlot №60 | Bioregulator of bone marrow cells |
| Endoluten №20 | Peptide of the pineal gland have a powerful antitumor effect |
Second month
for use in conjunction with the main treatment regimen
for use in conjunction with the main treatment regimen
778.00 €
| Indosine | Oncoprotector based on indole-3-carbinol, catalase and SOD |
| Ardiliv | Hepato- and angioprotector, source of DHQ and resveratrol |
| Mesotel Neo | Antioxidant, neuro- and hepatoprotector |
| Reviplant | Reduces intoxication, supports the liver, heart, brain, muscles and immune system |
| Vladonix №60 | Regulates the immune status |
| Panaxod | SOD source, oncoprotector and antioxidant |
| Revifort | Oncoprotective agent based on beta-D-glucans |
| Bonomarlot №60 | Биорегулятор клеток костного мозга |
| Endoluten №20 | Peptide of the pineal gland have a powerful antitumor effect |
Third month
for use in conjunction with the main treatment regimen
for use in conjunction with the main treatment regimen
369.00 €
| Calsil-Т | Source of calcium and magnesium |
| Imusil | Immune restorer |
| Felicita | Antioxidant |
| Olecap | Antioxidant, membrane stabilizer |
| Mesotel Beauty | Antioxidant, source of zinc and selenium |
| Revilab SL 03 | Immunomodulator |
| Zinsil-T | Source of zinc and pyridoxine |
| Ensil | Antioxidant and membrane stabilizer |
| Likam | Oncoprotective agent with a detoxifying effect |
| Levain | Oncoprotector, immunostimulant-lymphotonic |
Fourth month
for use in conjunction with the main treatment regimen
for use in conjunction with the main treatment regimen
309.00 €
| Calsil-Т | Source of calcium and magnesium |
| Imusil | Immune restorer |
| Olecap | Antioxidant, membrane stabilizer |
| Mesotel Beauty | Antioxidant, source of zinc and selenium |
| Zinsil-T | Source of zinc and pyridoxine |
| Ensil | Antioxidant and membrane stabilizer |
| Likam | Oncoprotective agent with a detoxifying effect |
| Levain | Oncoprotector, immunostimulant-lymphotonic |
Whole course
for use in conjunction with the main treatment regimen
for use in conjunction with the main treatment regimen
2128.00 €
| Calsil-Т | Source of calcium and magnesium |
| Indosine | Oncoprotector based on indole-3-carbinol, catalase and SOD |
| Ardiliv | Hepato- and angioprotector, source of DHQ and resveratrol |
| Imusil | Immune restorer |
| Felicita | Antioxidant |
| Mesotel Neo | Antioxidant, neuro- and hepatoprotector |
| Reviplant | Reduces intoxication, supports the liver, heart, brain, muscles and immune system |
| Vladonix №60 | Regulates the immune status |
| Olecap | Antioxidant, membrane stabilizer |
| Mesotel Beauty | Antioxidant, source of zinc and selenium |
| Panaxod | SOD source, oncoprotector and antioxidant |
| Revilab SL 03 | Immunomodulator |
| Zinsil-T | Source of zinc and pyridoxine |
| Revifort | Oncoprotective agent based on beta-D-glucans |
| Bonomarlot №60 | Bioregulator of bone marrow cells |
| Ensil | Antioxidant and membrane stabilizer |
| Likam | Oncoprotective agent with a detoxifying effect |
| Endoluten №20 | Peptide of the pineal gland have a powerful antitumor effect |
| Levain | Oncoprotector, immunostimulant-lymphotonic |
| Title | Quantity | Directions for use | Mechanism of action | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||